01 junio 2018

PharmaMar announces data presentations: Yondelis® and lurbinectedin at ASCO .

05/31/2018 | 07:44 pm.

By a News Reporter-Staff News Editor at Clinical Trials Week -- During the Congress of the American Society of Clinical Oncology (ASCO) that will be held form the 1st to the 5th of June in Chicago (USA), PharmaMar will present the data obtained from various clinical studies of the molecules Yondelis ®, lurbinectedin (PM1183) and plitidepsin (see also Pharmamar).